NCT07437469 Binaural Beats for Postoperative Pain and Anxiety Reduction
| NCT ID | NCT07437469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | TKA |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03-09 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-03-09 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To deliver a 30-minute binaural beats audio intervention in PACU and collect pain and anxiety outcomes immediately following surgery, and 4 hours following surgery completion in adults undergoing ambulatory total knee arthroplasty and total hip arthroplasty (TKA and THA).
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists Physical Status Classification System (ASA) 1-3 * Spinal anesthesia * Patients receiving nerve-block in Post-Anesthesia Care Unit (PACU) * Primary total hip or total knee arthroplasty Exclusion Criteria: * Moderate-severe hearing impairment or use of hearing aids * History of significant tinnitus, active delirium, chronic high-dose opioid therapy (\>60 MME/day baseline) * Major psychiatric pathology * General anesthesia
Contact & Investigator
Victor H Hernandez, MD, MSc
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT07437469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying TKA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07437469 currently recruiting?
Yes, NCT07437469 is actively recruiting participants. Contact the research team at arm577@miami.edu, doc.a.moya1@gmail.com for enrollment information.
Where is the NCT07437469 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT07437469 clinical trial?
NCT07437469 is sponsored by University of Miami. The principal investigator is Victor H Hernandez, MD, MSc at University of Miami. The trial plans to enroll 50 participants.